Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-09-27FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application from Apotex Corp. for a generic amlodipine/atorvastatin combination tablet.
-
FDA approval · 2022-09-26FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide. The spo…
-
FDA approval · 2022-09-26FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for nicardipine hydrochloride, enabling the marketing of this generic product…
-
FDA approval · 2022-09-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen's generic diltiazem hydrochloride under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Tailored Home-Based Exercise Program for Multiple Chronic Conditions [NA]
Completed clinical trial evaluating a tailored home-based exercise program for individuals with cancer, hypertension, and diabetes; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease [Phase 4]
Phase 4 clinical trial evaluating the effect of blood pressure control on improvement of left ventricular hypertrophy in hypertension patien…
-
FDA approval · 2022-09-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for a generic Losartan Potassium and Hydrochlorothiazide product by Lupin Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: N-of-1 Trials In Children With Hypertension [Phase 4]
Phase 4 clinical trial update on N-of-1 trials in children with hypertension has completed with posted results.
-
FDA approval · 2022-08-31FDA Approved: FUROSEMIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for furosemide from Hospira, Inc.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension [Phase 4]
Phase 4 trial updating the efficacy of Qianglidingxuan tablets for hypertension.
-
FDA approval · 2022-08-29FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Losartan Potassium, authorizing changes to an already approved generic …
-
FDA approval · 2022-08-29FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for olmesartan medoxomil submitted by Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS withdrawal · 2022-08-26Clinical Trial Update: Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy [Phase 4]
A Phase 4 clinical trial examining an intervention for high-normal blood pressure in adults with type 2 diabetes has been withdrawn.
-
FDA approval · 2022-08-26FDA Approved: CHLORTHALIDONE CHLORTHALIDONE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic chlorthalidone by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration [NA]
A terminated clinical trial evaluating intradialytic blood pressure slope-guided ultrafiltration in ESRD patients with extracellular fluid a…
-
FDA approval · 2022-08-17FDA Approved: VALSARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for valsartan from Jubilant Cadista Pharmaceuticals Inc. This approval indicates regulatory auth…
-
FDA approval · 2022-08-16FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for metoprolol succinate ER tablets.
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure [Phase 2]
Phase 2 trial assessing safety and efficacy of a topical spray B244 for people with elevated blood pressure (prehypertension and Stage I hyp…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback. [Phase 2, Phase 3]
Phase 2/3 trial update investigating patient-targeted feedback to increase risk perception of physical activity in hypertension and coronary…
-
FDA approval · 2022-08-08FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved an original-application for a generic labetalol hydrochloride product from Unichem Pharmaceuticals (USA), Inc., granting approv…
-
FDA approval · 2022-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals' generic diltiazem hydrochloride under an original ANDA.
-
FDA approval · 2022-08-04FDA Approved: CHLORTHALIDONE — Original Application (Lifestar Pharma LLC)
The FDA approved an original application for chlorthalidone from Lifestar Pharma LLC, a generic diuretic indicated for hypertension and edem…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment [Phase 3]
Phase 3 trial update comparing losartan with indapamide to Hyzaar in hypertension; study status suspended.
-
FDA approval · 2022-07-21FDA Approved: VALSARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for VALSARTAN from Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients [Phase 4]
Phase 4 trial assessing the effect of amlodipine on lipid profile in newly diagnosed hypertensive patients.